Trinity Biotech (NASDAQ: TRIB) has announced a strategic collaboration designed to accelerate the development of its innovative EpiCapture prostate cancer test. The partnership with a…
November 14, 2025
November 14, 2025
How ImmunityBio’s (IBRX) Revenue Growth and Narrowed Losses Could Influence Investor Sentiment
ImmunityBio Inc. (NASDAQ: IBRX),released its third-quarter and nine-month earnings earlier this month , showcasing a significant boost in revenue to $32.06 million for the quarter…